Literature DB >> 11054713

Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.

L Tornillo1, V Carafa, J Richter, G Sauter, H Moch, E Minola, M Gambacorta, L Bianchi, R Vecchione, L M Terracciano.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common neoplasms worldwide. Well-established risk factors include infections with two very different viruses: the DNA virus causing hepatitis B (HBV) and the RNA virus inducing hepatitis C (HCV). In order to determine whether genetic differences exist between HBV- and HCV-induced HCC, 41 HCC samples of known vival status were examined by comparative genomic hybridization (CGH). The analysis revealed frequent deletions of 1p (24%), 4q (39%), 6q (41%), 8p (44%), 9p (24%), 11q (24%), 12q (22%), and 13q (39%), as well as common gains of 1q (46%), 6p+ (20%), 8q+ (41%), 11q (27%), and 17q+ (37%). There was no significant difference in the number and type of chromosomal imbalances between 25 HCV- and 16 HBV-infected tumours. This is consistent with models suggesting that HBV and HCV cause cancer through non-specific inflammatory and regenerative processes, rather than through virus-specific interactions with defined target genes. Chromosomal imbalances were also unrelated to the grade and stage of HCC. This may suggest that most gross genomic alterations occur early during HCC development and that further progression of these tumours may be associated with other types of genetic changes, not detectable by CGH. In summary, these data show that characteristic gross genomic changes occur in HCC, but these alterations at present do not appear to have diagnostic or prognostic applications. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11054713     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH706>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Kazunari Sasaki; Junichi Shindoh; Yujiro Nishioka; Georgios A Margonis; Toshitaka Sugawara; Nikolaos Andreatos; Masaji Hashimoto; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-01-03       Impact factor: 3.452

2.  A potent modifier of liver cancer risk on distal mouse chromosome 1: linkage analysis and characterization of congenic lines.

Authors:  Andrea Bilger; L Michelle Bennett; Reynaldo A Carabeo; Teresa A Chiaverotti; Cecily Dvorak; Kristin M Liss; Susan A Schadewald; Henry C Pitot; Norman R Drinkwater
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

Review 3.  Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.

Authors:  Erzsébet Szabó; Csilla Páska; Pál Kaposi Novák; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 4.  Identification of drivers from cancer genome diversity in hepatocellular carcinoma.

Authors:  Atsushi Takai; Hien T Dang; Xin W Wang
Journal:  Int J Mol Sci       Date:  2014-06-20       Impact factor: 5.923

5.  Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study.

Authors:  Yajuan J Liu; Yang Zhou; Matthew M Yeh
Journal:  Mol Cytogenet       Date:  2014-11-25       Impact factor: 2.009

Review 6.  Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).

Authors:  Luca Quagliata; Manuel Schlageter; Cristina Quintavalle; Luigi Tornillo; Luigi M Terracciano
Journal:  Microarrays (Basel)       Date:  2014-04-15

7.  Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Authors:  Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

8.  Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data.

Authors:  Joseph J Crawley; Kyle A Furge
Journal:  Genome Biol       Date:  2002-11-25       Impact factor: 13.583

9.  Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.

Authors:  Ling Xu; Weiqi Dai; JingJing Li; Lei He; Fan Wang; Yujing Xia; Kan Chen; Sainan Li; Tong Liu; Jie Lu; Yingqun Zhou; Yugang Wang; Chuanyong Guo
Journal:  Oncotarget       Date:  2016-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.